LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model

• Hoofdauteurs: Po-Cheng Chang (Auteur), Shien-Fong Lin (Auteur), Yen Chu (Auteur), Hung-Ta Wo (Auteur), Hui-Ling Lee (Auteur), Yu-Chang Huang (Auteur), Ming-Shien Wen (Auteur), Chung-Chuan Chou (Auteur)
• Formaat: Boek
• Gepubliceerd in: Hindawi-Wiley, 2019-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background. LCZ696 (valsartan/sacubitril) therapy significantly reduced mortality in patients with heart failure (HF). Although a clinical trial (PARADISE-MI Trial) has been ongoing to examine the effects of LCZ696 in myocardial infarction (MI) patients, the effects of LCZ696 on remodeling of cardia...